---
title: 'Type 2 inflammation in COPD: is it just asthma?'
date: '2024-11-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39534492/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241114180137&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: COPD is a heterogeneous condition, with tobacco smoking being the main
  environmental risk factor. The presence of type 2 (T2) inflammation is a well-recognised
  feature of asthma; however, it is now apparent that a subset of COPD patients also
  displays evidence of T2 inflammation with respect to elevated eosinophil counts
  and altered gene and protein expression of several T2 inflammatory mediators. T2
  inflammatory mediators represent an attractive therapeutic target in both COPD and
  ...
disable_comments: true
---
COPD is a heterogeneous condition, with tobacco smoking being the main environmental risk factor. The presence of type 2 (T2) inflammation is a well-recognised feature of asthma; however, it is now apparent that a subset of COPD patients also displays evidence of T2 inflammation with respect to elevated eosinophil counts and altered gene and protein expression of several T2 inflammatory mediators. T2 inflammatory mediators represent an attractive therapeutic target in both COPD and ...